Advisory council’s recommendation may pave way for loosening of laws.
Doctors in the UK should be able to prescribe cannabis-derived medicine, the government’s chief drug advisers have recommended, paving the way for a loosening of the laws governing access to the substance.
The Advisory Council on the Misuse of Drugs (ACMD) has recommended after a review that cannabis-derived medicinal products should be placed in schedule 2 of the misuse of drugs regulations 2001, allowing them to be prescribed by clinicians.
Cannabis is classed as a schedule 1 drug, meaning it is thought to have no therapeutic value and cannot be lawfully possessed or prescribed. It may be used for the purposes of research but a Home Office licence is required.
– Read the entire article at The Guardian.